A novel protein encoded by circMAPK1 inhibits progression of gastric cancer by suppressing activation of MAPK signaling

Abstract

Background A novel type of noncoding RNA, circRNA has been reported to participate in the occurrence and development of diseases through many mechanisms. The MAPK pathway is a common signal transduction pathway involved in cell proliferation, inflammation and apoptosis and plays a particularly important role in cancers. However, the role of circRNAs related to the MAPK pathway in gastric cancer has not been explored. Methods A bioinformatics analysis was performed to profile and identify the circRNAs involved in the MAPK pathway in gastric cancer. The tumor-suppressive role of circMAPK1 was confirmed both in vitro and in vivo. Mass spectrometry, Western blot and immunofluorescence staining assays were used to validate the existence and expression of MAPK1–109aa. The molecular mechanism of circMAPK1 was investigated by mass spectrometry and immunoprecipitation analyses. Results In this study, we identified that circMAPK1 (hsa_circ_0004872) was downregulated in gastric cancer tissues compared with adjacent normal tissues. Importantly, lower circMAPK1 expression predicted poor survival in GC patients. CircMAPK1 inhibited the proliferation and invasion of gastric cancer cells in vitro and in vivo. Next, we found that circMAPK1 encoded a novel protein with 109 amino acids in length. Through a series of functional experiments, we confirmed that circMAPK1 exerted a tumor-suppressing effect via the encoded protein MAPK1–109aa. Mechanistically, the tumor suppressor MAPK1–109aa inhibited the phosphorylation of MAPK1 by competitively binding to MEK1, thereby suppressing the activation of MAPK1 and its downstream factors in MAPK pathway. Conclusions Our study revealed that circMAPK1 inhibits the malignant biological behavior of gastric cancer cells through its encoded protein MAPK1–109aa. More importantly, circMAPK1 is a favorable predictor for gastric cancer patients and may provide a new therapeutic target in the treatment of gastric cancer.

Pachymic acid inhibits inflammation and cell apoptosis in lipopolysaccharide (LPS)-induced rat model with pneumonia by regulating NF-κB and MAPK pathways

“…The effect of NF-κB/MAPK pathway on the progression of pneumonia have been clearly revealed. [20][21][22] NF-κB pathway could serve as a potential target for the treatment of pneumonia. Several drugs have been used for treating pneumonia through targeting NF-κB pathway.…”

Genome‑wide profiling of DNA methylation and gene expression unravel the epigenetic landscape in diabetes-related hypothyroidism

“…This finding suggested that the reduction of thyroid cells might be partly responsible for low thyroid hormone levels. Ras-Raf-MEK-MAPK signaling pathway was reported to be involved in numerous cellular and physiological processes essential to life including cell proliferation and cell growth [ 31 ]. The KEGG analysis of DMRs revealed that Ras and MAPK signaling pathways were dysregulated in high-glucose-cultured Nthy-ori3-1 cells.…”

Exosomal circRNA in Digestive System Tumors: The Main Player or Coadjuvants?

“…It has been reported that miR-503-3p in exosomes derived from bone marrow mesenchymal stem cells can increase the content of cancer stem cells in colorectal cancer, thereby promoting the growth of colorectal cancer ( 63 ). In addition to acting as competitive endogenous RNA, recent studies have found that circRNA with internal ribosome entry site (IRES) can bind to ribosomes and encode short peptides and proteins, thus directly regulating the function of tumor cells ( 64 ). Last but not least, as transcription factors or protein scaffolds, some circRNA interact directly with proteins to regulate the biological behavior of tumor cells ( 65 ).…”